Research News and Research

RSS

Gladstone-led study sheds light on critical molecular process

One of biology's most fundamental processes is something called transcription. It is just one step of many required to build proteins-and without it life would not exist. However, many aspects of transcription remain shrouded in mystery. But now, scientists at the Gladstone Institutes are shedding light on key aspects of transcription, and in so doing are coming even closer to understanding the importance of this process in the growth and development of cells-as well as what happens when this process goes awry.

8 Nov 2013

Life-saving bone marrow transplants may also cure peanut allergies

Not only can bone marrow transplants be life-saving for children with acute lymphocytic leukemia, they may also cure peanut allergies. According to research presented during the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting, a 10-year-old boy no longer had a peanut allergy after undergoing a bone marrow transplant.

8 Nov 2013

Report: Postmastectomy pain rated as most troubling symptom by breast cancer survivors

More than 40 percent of 200,000 U.S. women diagnosed with breast cancer every year undergo surgery. Though treatment advances have significantly reduced mortality from breast cancer, a study published in The Journal of Pain reported that persistent postmastectomy pain is rated by survivors as their most troubling symptom. The Journal of Pain is published by the American Pain Society, www.americanpainsociety.org.

8 Nov 2013

Viewpoints: The battle over one woman's medical story; why Mass. didn't see a wave of cancellations; politicians' love of anecdotes

Edie Littlefield Sundby may not have thought she'd ignite a national debate when the stage-4 cancer survivor asked us to publish her Monday op-ed on losing her oncologist due to the Affordable Care Act. But she certainly has, and it's important to understand why. Mrs. Sundby and millions like her must be denied their medical choices if ObamaCare is going to work as its liberal planners intend (11/6).

8 Nov 2013

Cancer research leaders announce the opening of ICGC-TCGA-DREAM SMC Challenge

Cancer research leaders from the Ontario Institute for Cancer Research and the University of California, Santa Cruz, in collaboration with Sage Bionetworks and IBM's DREAM, will announce tomorrow the opening of the ICGC-TCGA-DREAM Somatic Mutation Calling Challenge at the Sixth Annual RECOMB/ISCB conference.

8 Nov 2013

Top IT official for Healthcare.Gov resigns

Tony Trenkle, the federal official responsible for Healthcare.gov's launch and security, is moving to the private sector. CBS News reports that Trenkle was supposed to sign off on the site's security before launch but didn't.

8 Nov 2013

Antibe Founder and Chief Science Officer honored with Heymans Foundation Memorial Medal

Antibe Therapeutics Inc. is proud to announce that Dr. John Wallace, the Corporation's Founder and Chief Science Officer, was awarded the Heymans Foundation Memorial Medal in Ghent, Belgium, today.

8 Nov 2013

Four-year study to develop targeted approach to psoriasis treatment

A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's individual biological make-up.

8 Nov 2013

Cancer pioneer James Allison wins 2013 Innovations Award for bioscience

For basic science research that opened a completely new approach for treating cancer, The Economist has named James Allison, Ph.D., professor and chair of Immunology at The University of Texas MD Anderson Cancer Center, as its 2013 Innovations Award winner in Bioscience.

8 Nov 2013

Humana offers perspective on how botched Healthcare.gov rollout has affected insurance industry

In a Wednesday call with investors, the company's chief operating officer said Humana assumes that, because of the website problems, the government will extend the open enrollment period beyond its current March 31 cutoff. The insurer also scaled back its estimates of how many people will sign up for new coverage options.

8 Nov 2013

Discovery could rev up body's immune response to infection, autoimmune diseases

UT Southwestern Medical Center researchers report that disrupting the light-dark cycle of mice increased their susceptibility to inflammatory disease, indicating that the production of a key immune cell is controlled by the body's circadian clock.

8 Nov 2013

Asthma inhalers with dose counters lessen emergency room visits by 55%

Asthma is the most common chronic illness and is responsible for 2.1 million emergency room visits annually. But according to a study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, these costly visits can be reduced by 55 percent when inhalers contain a simple dose counter.

8 Nov 2013

Clinical testing expanded for vaccine against latent TB

Statens Serum Institut and Aeras today announced the initiation of a Phase I/IIa clinical trial for a candidate tuberculosis vaccine designed to protect people, especially those latently infected with TB, from developing active TB disease.

8 Nov 2013

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

8 Nov 2013

State highlights: Officials seek public watchdog for health system money

Republicans cite their 2.5-point defeat in the Virginia governor's race as proof that Ken Cuccinelli would have reversed his fortunes if he'd hammered earlier and longer on Obamacare, an issue the attorney general said tightened the contest in its final days (Davis and McCormick, 11/7).

8 Nov 2013

Findings raise prospects for new therapies to protect heart from progressive disease

Some of the most commonly prescribed drugs for the treatment of heart failure are beta-blockers and nitrates, which help to relax blood vessels and decrease the heart's workload. The drugs were thought to produce those effects through distinct molecular pathways, but according to a new study led by scientists at Temple University School of Medicine, both types of drugs may help the failing heart by counteracting the effects of an enzyme known as GRK2.

8 Nov 2013

Sebelius says Healthcare.gov fixes coming, rejects calls for delay

Health and Human Services Secretary Kathleen Sebelius sought to reassure lawmakers in a Senate Finance Committee hearing Wednesday that fixes -- hundreds of them -- are being made to Healthcare.gov, but rejected calls to delay the law or shut the website down.

8 Nov 2013

Cholesterol metabolite promotes tumor growth in breast cancers

A team of researchers at UT Southwestern has found that as cholesterol is metabolized, a potent stimulant of breast cancer is created - one that fuels estrogen-receptor positive breast cancers, and that may also defeat a common treatment strategy for those cancers.

8 Nov 2013

Longer looks: Bad behavior treatment; end of life decisions

Every week reporter Ankita Rao selects interesting reading from around the Web.

8 Nov 2013

For some republicans, support for Medicaid expansion draws new adversaries

The Los Angeles Times examines the political backlash in Ohio to GOP lawmakers who supported the Medicaid expansion. Meanwhile, CQ HealthBeat reports on efforts to phase-in the electronic data system that will send states information about people who appear to be eligible for Medicaid who have tried to sign up for coverage through healthcare.gov.

8 Nov 2013

Research News and Research

Gladstone-led study sheds light on critical molecular process

Life-saving bone marrow transplants may also cure peanut allergies

Report: Postmastectomy pain rated as most troubling symptom by breast cancer survivors

Viewpoints: The battle over one woman's medical story; why Mass. didn't see a wave of cancellations; politicians' love of anecdotes

Cancer research leaders announce the opening of ICGC-TCGA-DREAM SMC Challenge

Top IT official for Healthcare.Gov resigns

Antibe Founder and Chief Science Officer honored with Heymans Foundation Memorial Medal

Four-year study to develop targeted approach to psoriasis treatment

Cancer pioneer James Allison wins 2013 Innovations Award for bioscience

Humana offers perspective on how botched Healthcare.gov rollout has affected insurance industry

Discovery could rev up body's immune response to infection, autoimmune diseases

Asthma inhalers with dose counters lessen emergency room visits by 55%

Clinical testing expanded for vaccine against latent TB

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

State highlights: Officials seek public watchdog for health system money

Findings raise prospects for new therapies to protect heart from progressive disease

Sebelius says Healthcare.gov fixes coming, rejects calls for delay

Cholesterol metabolite promotes tumor growth in breast cancers

Longer looks: Bad behavior treatment; end of life decisions

For some republicans, support for Medicaid expansion draws new adversaries

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery